Overview

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
JeniVision, Inc.
Treatments:
Latanoprost
Ophthalmic Solutions